Fig. 2From: Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective studySensitivity and specificity of the biomarker for HCC. (a and b) ROC curve analysis for the performance of the GPC3, GLS1, and AFP and their combination to diagnose HCCBack to article page